Math over Myth

Math Over Myth: Compass and Revive Release Phase 3 Updates but Stocks Drop

,
Math over Myth is your weekly source for psychedelic stock updates, including Compass Pathways and Revive Therapeutics
Math over Myth

Math Over Myth: These Psychedelic Stocks Made Confirmed Bottoms in Q3

,
Math over Myth is your weekly update on psychedelic stocks and ETFs, including ATAI, COMPASS, Cybin, GH Research, Mindset, Numinus, and more
Math over Myth

Math Over Myth: Weekly Psychedelic Stocks News Roundup

,
Get the latest news on psychedelic stocks Cybin, Numinus, MindMed, ATAI, Mindset, Braxia, Tryp, Irwin Naturals, and Revive
Math over Myth

Math Over Myth: September Psychedelic Stock News Roundup

,
Track the monthly performance of the psychedelic stock sector with our Math over Myth Stock News Roundup
Math over Myth

Math Over Myth: MindMed’s Self Destructive Stock Mission

,
Psychedelic stock MindMed enters free fall as news of a private equity offering of common stock spooks retail investors
Havn Life Collapses

Math Over Myth: Psychedelic Stock HAVN Life Collapses

,
The psychedelic corporate shakeout continues as another company, HAVN Life Sciences, folds due to lack of cash flow
Psychedelics in Palliative Care

End of Life: Psychedelics in Palliative Care

,
We interview Dr. Paul Thielking, Chief Science Officer of Numinus, about the use of psychedelics in palliative care and end of life care
Math over Myth MindMed

Math Over Myth: Spotlight on MindMed

,
In the latest installment of Math Over Myth we navigate psychedelic stock MindMed’s reverse split with Fibonacci numbers
Math over Myth ATAI Compass

Math Over Myth: Spotlight on Psychedelic Stocks ATAI & COMPASS

,
If you want to invest in psychedelic stocks, ignore the hype and look at the technicals. We take a deep dive on atai Life Sciences & COMPASS Pathways
ARK Invest psychedelic

Psychedelic Stocks: ARK Invest and the Reverse Midas Touch

, ,
Cathie Wood is buying up stocks from the most dubious actors in the psychedelic sector. Given ARK Invest’s subpar performance, is that a good thing?